Skip Navigation Hotkeys

Search and Service

Assistive Product PARI BOY Classic

Product Type:

Nozzle nebulizer

Indications:

- bronchial asthma and allergic asthma
- acute and chronic bronchitis
- atelectasis or bronchiectasis

Description:

The PARI BOY Classic in a new design replaces the PARI TurboBOY SX. The device is used for the therapy of illnesses in children, adolescents and adults such as bronchial asthma, allergic asthma and acute or chronic bronchitis.

Features / Components:

- inhalation time less than 5 min. for 2.5 ml inhalation solution (salbutamol)
- PARI LC SPRINT nebuliser for efficient lung deposition even with short inhalation times
- integrated "training tool" PIF-Control supports learning an effective inhalation technique
- universal mouthpiece
- blue nozzle attachment
- connection tube
- 4-year warr

Price (without guarantee):

Price is available upon request from the manufacturer/distributor.

SHI-Number:

SHI-Medical Technical Aids Register | 14.24.01.0150

Product Information from the Manufacturer / Distributor:

Further Product Details

Further Information

REHADAT does not sell any products

Please contact the manufacturer or distributor.

Manufacturer:

PARI Medical Holding GmbH
Moosstr. 3
82319 Starnberg
Germany Telephone: 08151 279-0 Email: info@pari.de Homepage: https://www.pari.com

Distributor:

PARI Medical Holding GmbH
Moosstr. 3
82319 Starnberg
Germany Telephone: 08151 279-0 Email: info@pari.de Homepage: https://www.pari.com

Technical Data:


Weight: 1.7 kg
Dimensions (W x H x D): 18.5 x 13 x 15 cm
Voltage: 230 V AC, 50 Hz
Operating noise: 56 dB(A)
Nebulizer output: 600 mg/min (blue nozzle attachment)
Pressure: 1.6 bar
Compressor flow: 5.0 l/min
Med. Mass Diameter: 4.7 microns (blue nozzle attachment)
Particle Size: 62% < 5 microns (blue nozzle attachment)
Pharma Central Number: 13868409

Keywords

ISO

Search for similar prodcuts in REHADAT:
Search for similar products in EASTIN throughout Europe:

ICF Items

Reference Number:

Hil135646


Source :

DIAS


Last Update: 8 Aug 2022